Eikon Therapeutics, Inc.
NASDAQEIKN heads into its June 26 earnings release with short sellers adding pressure even as the stock slides — a tension that makes tonight's print unusually binary for a pre-revenue biotech. Short interest has climbed roughly 23% over the past month to around 4.3 million shares, with the ORTEX short score running at 83.4 — near the high of the recent range. That score has ticked…
Snapshot as of 26 Jun 2026
EIKN heads into its June 26 earnings release with short sellers adding pressure even as the stock slides — a tension that makes tonight's print unusually binary for a pre-revenue biotech. Short interest has climbed…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EIKN — free to start on ORTEX.
Sign up for free →Open EIKN on ORTEX